Gemcitabine, Docetaxel, and Hydroxychloroquine in Treating Participants With Recurrent or Refractory Osteosarcoma
Clinical trial NCT03598595 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03598595
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-28
- Primary completion
- 2027-05-31
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.